Form 483

Collegium Pharmaceutical, Inc Form 483, 2010-08-31

FDA issued a Form 483 to Collegium Pharmaceutical, Inc on 2010-08-31 with 8 public-safe observations.

483· Form 483 issued8 observations

Collegium Pharmaceutical, Inc · Stoughton, United States · Issued August 31, 2010

Overview

  • 8 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

31 Aug 2010
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Robert J Martin, Suzanne M Healy, Margaret E Walsh

31 Aug 2010
21 CFR 211.25(b)

Supervisor Training/Education/Experience

Cited by Robert J Martin, Suzanne M Healy, Margaret E Walsh

31 Aug 2010
21 CFR 211.67(b)

Written procedures fail to include

Cited by Robert J Martin, Suzanne M Healy, Margaret E Walsh

31 Aug 2010
21 CFR 211.68(a)

Calibration/Inspection/Checking not done

Cited by Robert J Martin, Suzanne M Healy, Margaret E Walsh

31 Aug 2010
21 CFR 211.160(a)

Following/documenting laboratory controls

Cited by Robert J Martin, Suzanne M Healy, Margaret E Walsh

Inspected site

CPCollegium Pharmaceutical, IncStoughton, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.25(b)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.68(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 8 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere